Relief Therapeutics Holding AG (RLFTF)

[tcm55]

LS5 is asking for answers to specific poster statements that I'm reading now, too. There has been implications by posters here of inside help at the FDA, etc, and connections to shorten normal Paths and required Clinical Trial DATA.

Maybe skip back to the Question of what RLF gets for all it DOES (funds development of RLF100)(VIP manufacturing)(+$40M on the books) in this deal Dr JJ promotes for NRX and the unnamed NYSE pharma IPO/rev merge, backed by up to $150M from GEM. Is the RLF/NRX 'Profit' share plan changed?